Impact of Insurance Status on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma
Castro D, Gebrael G, Meza L, Li X, Tripathi N, Tandar C, Sayegh N, Zengin Z, Chehrazi-Raffle A, Govindarajan A, Dizman N, Barragan-Carrillo R, Ebrahimi H, Mercier B, Chawla N, Jaime-Casas S, Salgia N, Zugman M, Hsu J, Philip E, Bergerot C, Agarwal N, Pal S. Impact of Insurance Status on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma. JCO Oncology Advances 2025 DOI: 10.1200/oa.24.00015.Peer-Reviewed Original ResearchMetastatic renal cell carcinomaProgression-free survivalImpact of insurance statusOverall survivalRenal cell carcinomaSurvival outcomesCell carcinomaAssociated with significantly better PFSAssociated with significantly better survival outcomesAssociated with better progression-free survivalInsurance statusFirst-line systemic therapyMedicaid/no insuranceBetter survival outcomesKaplan-Meier methodLog-rank testAssociated with lower riskSystemic therapyPrimary insurance typeNo significant differenceNational Cancer Institute-designated cancer centerInstitutional databasePrivate insuranceCancer CenterLow risk
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply